Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2283 publications
Vascular endothelial cells and angiogenesis.
Journal: Pharmacological research
Published: October 04, 2025
Regorafenib as maintenance therapy showed significant delayed progression of non-adipocytic soft tissue sarcomas.
Journal: CA: a cancer journal for clinicians
Published: September 13, 2025
Correction: Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.
Journal: Oncotarget
Published: August 29, 2025
RETRACTION: Involvement of Notch-1 in Resistance to Regorafenib in Colon Cancer Cells.
Journal: Journal of cellular physiology
Published: August 22, 2025
The SCD1 inhibitor aramchol interacts with regorafenib to kill GI tumor cells in vitro and in vivo.
Journal: Oncotarget
Published: August 19, 2025
Present management of gastrointestinal stromal tumors.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: August 05, 2025
Health-related quality-of-life outcomes with regorafenib in advanced gastric and esophagogastric junction cancer: results from the INTEGRATE trials.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: July 26, 2025
Cost-effectiveness analysis of first-line treatment for advanced soft tissue sarcomas in China.
Journal: Journal of medical economics
Published: July 25, 2025
Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group study.
Journal: Scientific reports
Published: July 18, 2025
Targeting Cell-Matrix Induced Chemoresistance With Regorafenib in a 3D Model of Osteosarcoma.
Journal: Journal of biomedical materials research. Part A
Published: July 13, 2025
Identification of FDA-Approved Drugs That Inhibit SARS-CoV-2 and Human Norovirus Replication.
Journal: Biological & pharmaceutical bulletin
Published: July 09, 2025
Last Updated: 10/31/2025